Phase
Condition
Bipolar Disorder
Mood Disorders
Treatment
N/AClinical Study ID
Ages 12-17 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
age between 12 and 17 years and 11 months;
current clinical state of euthymia (patient stable or euthymic) after clinicalevaluation, defined as the presence of clinical remission (CDRS ≤ 40, YMRS ≤ 12.5 andCGAS (Children's Global Assessment Scale) ≥ 51), being the presence of subsyndromicsymptoms (YMRS> 8 and <14) admissible;
Presence of one or more distressing traumatic events, assessed by:
Trauma subscale of the Post Traumatic Stress Disorder Questionnaire from theSchedule for Affective Disorders and Schizophrenia for School Aged ChildrenPresent and Lifetime Version (K-SADS-PL) , with frequency> 1;
Holmes Rahes Stress Inventory for non-adults (H-RLSI) with frequency> 1;
Children Revised Impact of Event Scale (CRIES)> 0;
Childhood Trauma Questionnaire (CTQ)> 0; and
at least 5 points in the disturbance assessment by the Subjective Units ofDisturbance (SUDS) scale.
Exclusion
Exclusion Criteria:
substance abuse / dependence within 3 months prior to participation;
neurological disease or history of brain trauma;
autism;
Intelligence Quotient <70;
suicidal or homicidal ideation;
prior involvement in trauma-focused therapy;
psychotherapy during the study and months of follow-up, and;
a score greater than 25 on the Adolescent Dissociative Experience Scale, since thepresence of massive dissociation requires different and more extensive treatmentprotocols.
Study Design
Study Description
Connect with a study center
Centro de Pesquisas Clínicas do Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande Do Sul 90035-007
BrazilActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.